RecruitingNCT00398177
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Sponsor
Stanford University
Enrollment
9,999 participants
Start Date
Jan 1, 1999
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study collects clinical information and tissue samples from patients with non-Hodgkin's lymphoma (a type of blood cancer) and related conditions, to improve understanding of these diseases and how they respond to treatment.
**You may be eligible if...**
- You have been diagnosed with non-Hodgkin's lymphoma or a related blood disorder
- You are willing to provide tissue samples and allow access to your medical records
- You are 18 years of age or older
**You may NOT be eligible if...**
- You are unable or unwilling to provide informed consent
- You have another serious illness that would affect your ability to participate
- You do not have a confirmed diagnosis of the conditions being studied
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00398177
Related Trials
Tissue Collection for Studies of Lymph Cancer
NCT016768052 locations
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT075197724 locations
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
NCT076525803 locations
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
NCT054425151 location
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
NCT0493568420 locations